Order

Size
Price
Stock
Qty

NHI 2

Axon 2450
Based on 24 publications in PubMed
CAS:  1269802-97-2
Purity:  99%
  • Soluble in DMSO
  • MF:  C17H12F3NO3
  • MW:  335.28

Description

NHI 2 is a cell-permeable inhibitor of lactate dehydrogenase A (LDH-A) with selectivity over LDH-B. It suppresses glycolytic lactate production and is used to investigate cancer metabolism.

LDH-A supports aerobic glycolysis by converting pyruvate to lactate and regenerating NAD+ in highly glycolytic cells. NHI 2 is useful for studying metabolic reprogramming, Warburg-effect biology and LDH-A-dependent tumor cell viability.

Key Features

  • LDH-A inhibitor
  • Reported IC50 values: 14.7 µM for LDH-A and 55.8 µM for LDH-B
  • Cell-permeable glycolysis-modulating compound
  • Reduces LDH-A-dependent lactate pathway activity

Applications

  • Cancer metabolism research
  • LDH-A enzyme pharmacology
  • Glycolysis and Warburg-effect assays
  • Metabolic vulnerability studies in tumor cells

Related Products

AXON ID NAME FROM PRICE
1204 EBPC

From $90.20

1756 BVT 2733 hydrochloride

From $99.00

2043 Atorvastatin calcium

From $66.00

2122 AGI 5198

From $66.00

2149 Mitapivat

From $121.00

2175 3PO

From $71.50

2240 TEPP-46

From $99.00

2274 AGI 6780

From $99.00

3621 GSK2837808A

From $143.00

Loading...